REINDR Trademark

Trademark Overview

On Friday, May 5, 2017, a trademark application was filed for REINDR with the United States Patent and Trademark Office. The USPTO has given the REINDR trademark a serial number of 87438724. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2019. This trademark is owned by Rare Genetix, Inc.. The REINDR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical molecular preparations for the treatment of RNA-driven orphan cancers and other rare biological diseases
reindr

General Information

Serial Number87438724
Word MarkREINDR
Filing DateFriday, May 5, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 19, 2018

Trademark Statements

Goods and ServicesPharmaceutical molecular preparations for the treatment of RNA-driven orphan cancers and other rare biological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 11, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRare Genetix, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameRare Genetix, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, March 18, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 18, 2019ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 14, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 19, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 19, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 30, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 10, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, May 10, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 10, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, May 10, 2018EXAMINERS AMENDMENT -WRITTEN
Sunday, March 11, 2018NOTIFICATION OF FINAL REFUSAL EMAILED
Sunday, March 11, 2018FINAL REFUSAL E-MAILED
Sunday, March 11, 2018FINAL REFUSAL WRITTEN
Wednesday, February 14, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 14, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 14, 2018ASSIGNED TO LIE
Tuesday, February 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, August 13, 2017NON-FINAL ACTION E-MAILED
Sunday, August 13, 2017NON-FINAL ACTION WRITTEN
Wednesday, August 2, 2017ASSIGNED TO EXAMINER
Thursday, May 11, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 9, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

reindr other rare biological diseases cancers orphan molecular preparations treatment driven